Kyowa Kirin Co., Ltd. Company profile
About Kyowa Kirin Co Ltd
Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Kyowa Kirin Co Ltd revenues increased 11% to Y352.25B. Net income increased 11% to Y52.35B. Revenues reflect Manufactured goods segment increase of 9% to Y326.14B, Technical income segment increase of 34% to Y26.11B, Americas segment increase of 42% to Y102.16B, Europe segment increase of 10% to Y53.36B. Net income also reflects Equity in Loss/Earning of Affiliates increase from Y964M to Y4.58B (income).
Equity composition
The Company changed its FYE from Dec. to Mar during FY'96. FY'06 Q1 is restated. FY'08 Q1 DWAS was estimated and WSA was used as O/S. FY'08 3Q WAS=O/S. 10/2008, Company name changed from KYOWA HAKKO KOGYO CO., LTD. FYE changed from Mar to Dec during FY'09.